Newsroom
Category
October 20, 2023
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Oct. 20, 2023 – UT Health San Antonio has earned a “Best Company Perks & Benefits” award from Comparably, a website that compiles job listings and company culture information, based on feedback from surveys of its current employees. This marks the third award UT Health San Antonio […]
October 19, 2023
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Oct. 19, 2023 – UT Health San Antonio has been recognized as a “Digital Health Most Wired” organization by the College of Healthcare Information Management Executives (CHIME), an organization serving senior health care information technology leaders. The award is based on an annual survey designed to identify […]
October 16, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 16, 2023 – Mays Cancer Center at UT Health San Antonio will host the third annual San Antonio Liver Cancer Symposium on October 20 and 21 at the Hilton San Antonio Hill Country. The two-day event will bring together health care professionals from around the world to […]
October 16, 2023
The most famous textbook in interventional cardiology, Grossman and Baim’s “Cardiac Catheterization, Angiography and Intervention,” now bears the name of The University of Texas Health Science Center at San Antonio on its inside cover. Marc D. Feldman, MD, emeritus and adjoint professor of medicine in the Janey and Dolph Briscoe Division of Cardiology, worked with […]
October 12, 2023
Media contact: Will Sansom, sansom@uthscsa.edu, (210) 567-2579 On-site contact: Julie Collins, collinsjr@uthscsa.edu, (210) 218-8746 SAN ANTONIO (Oct. 12, 2023) – Hundreds of individuals from around the world will gather in San Antonio Oct. 17-18 to focus on the psychological health needs of military service members and veterans. With 2023 marking 50 years since the end […]
October 6, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto […]
